Programme

Overview: Mini-Orals are presented at one of the sessions scheduled in the two mini-oral theatres. Each author will present a 4-slide PowerPoint orally for 4 minutes, followed by 3 minutes for discussion. Sessions will be recorded and made available via the online platform and mobile app.

Overview: In this symposium, the latest advancements in Interventional Radio-Immunotherapy will be discussed, emphasizing the synergy between radiotherapy and immunotherapy to improve cancer treatment outcomes, with a special focus on brachytherapy (Interventional radiotherapy). The lectures will cover radiobiological aspects, including the effects of different radiation types and dose rates, and address challenges in dose distribution. Additionally, the symposium will focus on specific tumors such as gynecological, head, neck, skin, and urological cancers. Ongoing clinical trials and future directions will be explored, with an emphasis on personalized approaches based on tumor immune profiling to optimize treatment efficacy.

Overview: A substantial part of the head and neck patients are more than 70 years of age at diagnosis. This calls for special considerations when deciding the treatment in collaboration with the patient and the relatives. Who can be treated according to international guidelines? Who needs a modified curative regime (and what can that be in terms of radiotherapy and/or systemic treatment) and for whom is palliation the best choice? How do we decide and what outcomes can be expected? After the session, the attendee will have a good overview of this challenging topic.

Overview: Proffered Papers are presented in one of the sessions scheduled in the main session halls. Each author will present orally for 7 minutes, followed by 3 minutes for discussion. Sessions will be recorded and available on-demand.